Transition and Transfer to Adult Care for Adolescents and Young Adults with Advanced Chronic Kidney Disease

2021 ◽  
pp. 793-810
Author(s):  
Lorraine E. Bell ◽  
Dirk Bethe
Keyword(s):  
Chronic Kidney Disease ◽  
Young Adults ◽  
Kidney Disease ◽  
Adolescents And Young Adults ◽  
Adult Care ◽  
Advanced Chronic Kidney Disease

Alcohol, cigarette, e-cigarette and marijuana use among adolescents and young adults with chronic kidney disease in North America

2021 ◽  
Author(s):  
Andrea R. Molino ◽  
Judith Jerry-Fluker ◽  
Meredith A. Atkinson ◽  
Susan L. Furth ◽  
Bradley A. Warady ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Young Adults ◽  
Kidney Disease ◽  
North America ◽  
Marijuana Use ◽  
Adolescents And Young Adults

Executive Functioning in Children, Adolescents, and Young Adults with Chronic Kidney Disease

2015 ◽  
Vol 36 (9) ◽  
pp. 734-742 ◽  
Author(s):  
Stephen R. Hooper ◽  
Nina Laney ◽  
Jerilynn Radcliffe ◽  
Divya Moodalbail ◽  
Erum A. Hartung ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Young Adults ◽  
Kidney Disease ◽  
Executive Functioning ◽  
Adolescents And Young Adults

Self-Management and Health Care Transition Among Adolescents and Young Adults With Chronic Kidney Disease: Medical and Psychosocial Considerations

2017 ◽  
Vol 24 (6) ◽  
pp. 405-409 ◽  
Author(s):  
Maria E. Díaz-González de Ferris ◽  
Marta Del Villar-Vilchis ◽  
Ricardo Guerrero ◽  
Victor M. Barajas-Valencia ◽  
Emily B. Vander-Schaaf ◽  
...  
Keyword(s):  
Health Care ◽  
Chronic Kidney Disease ◽  
Young Adults ◽  
Kidney Disease ◽  
Adolescents And Young Adults ◽  
Self Management ◽  
Care Transition ◽  
Health Care Transition

Phosphate binders in patients with chronic kidney disease: Between the new and the old.

2019 ◽  
pp. 2-3
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Estimated Glomerular Filtration Rate ◽  
Chronic Kidney Disease Stage ◽  
Disease Stage ◽  
Phosphate Binders ◽  
Advanced Chronic Kidney Disease ◽  
Phosphate Retention ◽  
Stage 4 ◽  
Dietary Phosphate

Impaired phosphate excretion by the kidney leads to Hyperphosphatemia. It is an independent predictor of cardiovascular disease and mortality in patients with advanced chronic kidney disease (stage 4 and 5) particularly in case of dialysis. Phosphate retention develops early in chronic kidney disease (CKD) due to the reduction in the filtered phosphate load. Overt hyperphosphatemia develops when the estimated glomerular filtration rate (eGFR) falls below 25 to 40 mL/min/1.73 m2. Hyperphosphatemia is typically managed with oral phosphate binders in conjunction with dietary phosphate restriction. These drugs aim to decrease serum phosphate by binding ingested phosphorus in the gastrointestinal tract and its transformation to non-absorbable complexes [1].

Sign in / Sign up

Export Citation Format

Share Document